|
|
||||||||
1 Division of Hypertension and Vascular Research, Henry Ford Hospital, Detroit, Michigan 48202; and 2 Vascular Biology Center, Medical College of Georgia, Augusta, Georgia 30912
Endothelin-1
(ET-1) inhibits transport in various nephron segments, and the thick
ascending limb of the loop of Henle (TALH) expresses ET-1
receptors. In many tissues, activation of ETB receptors stimulates release of NO, and we recently reported that endogenous NO
inhibits TALH chloride flux (JCl). However, the
relationship between ET-1 and NO in the control of nephron transport
has not been extensively studied. We hypothesized that ET-1 decreases NaCl transport by cortical TALHs through activation of ETB
receptors and release of NO. Exogenous ET-1 (1 nM) decreased
JCl from 118.3 ± 15.0 to 62.7 ± 13.6 pmol · mm
1 · min
1 (48.3 ± 8.2% reduction), whereas removal of ET-1 increased
JCl in a separate group of tubules from
87.6 ± 10.7 to 115.2 ± 10.3 pmol · mm
1 · min
1 (34.5 ± 6.2%
increase). To determine whether NO mediates the inhibitory effects of
ET-1 on JCl, we examined the effect of
inhibiting of NO synthase (NOS) with
NG-nitro-L-arginine methyl ester
(L-NAME) on ET-1-induced changes in
JCl. L-NAME (5 mM) completely
prevented the ET-1-induced reduction in JCl,
whereas D-NAME did not. L-NAME alone had no
effect on JCl. These data suggest that the
effects of ET-1 are mediated by NO. Blockade of ETB
receptors with BQ-788 prevented the inhibitory effects of 1 nM ET-1.
Activation of ETB receptors with sarafotoxin S6c mimicked
the inhibitory effect of ET-1 on JCl (from
120.7 ± 12.6 to 75.4 ± 13.3 pmol · mm
1 · min
1). In contrast,
ETA receptor antagonism with BQ-610 did not prevent ET-1-mediated inhibition of TALH JCl (from
96.5 ± 10.4 to 69.5 ± 8.6 pmol · mm
1 · min
1). Endothelin increased
intracellular calcium from 96.9 ± 14.0 to 191.4 ± 11.9 nM,
an increase of 110.8 ± 26.1%. We conclude that exogenous
endothelin indirectly decreases TALH JCl by
activating ETB receptors, increasing intracellular calcium
concentration, and stimulating NO release. These data suggest that
endothelin acts as a physiological regulator of TALH NO synthesis, thus
inhibiting chloride transport and contributing to the natriuretic
effects of ET-1 observed in vivo.
kidney; nitric oxide; tubular transport
This article has been cited by other articles:
![]() |
G. R. Ares, P. Caceres, F. J. Alvarez-Leefmans, and P. A. Ortiz cGMP decreases surface NKCC2 levels in the thick ascending limb: role of phosphodiesterase 2 (PDE2) Am J Physiol Renal Physiol, October 1, 2008; 295(4): F877 - F887. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Evans Teleost fish osmoregulation: what have we learned since August Krogh, Homer Smith, and Ancel Keys Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2008; 295(2): R704 - R713. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Schneider, Y. Ge, D. M. Pollock, J. S. Pollock, and D. E. Kohan Collecting Duct-Derived Endothelin Regulates Arterial Pressure and Na Excretion via Nitric Oxide Hypertension, June 1, 2008; 51(6): 1605 - 1610. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Nakano, J. S. Pollock, and D. M. Pollock Renal medullary ETB receptors produce diuresis and natriuresis via NOS1 Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1205 - F1211. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Schneider, E. W. Inscho, and D. M. Pollock Attenuated vasoconstrictor responses to endothelin in afferent arterioles during a high-salt diet Am J Physiol Renal Physiol, April 1, 2007; 292(4): F1208 - F1214. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ge, A. Bagnall, P. K. Stricklett, K. Strait, D. J. Webb, Y. Kotelevtsev, and D. E. Kohan Collecting duct-specific knockout of the endothelin B receptor causes hypertension and sodium retention Am J Physiol Renal Physiol, December 1, 2006; 291(6): F1274 - F1280. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wendel, L. Knels, W. Kummer, and T. Koch Distribution of Endothelin Receptor Subtypes ETA and ETB in the Rat Kidney J. Histochem. Cytochem., November 1, 2006; 54(11): 1193 - 1203. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tsuruoka, S. Watanabe, J. M. Purkerson, A. Fujimura, and G. J. Schwartz Endothelin and nitric oxide mediate adaptation of the cortical collecting duct to metabolic acidosis Am J Physiol Renal Physiol, October 1, 2006; 291(4): F866 - F873. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Pollock and M. P. Schneider Clarifying Endothelin Type B Receptor Function Hypertension, August 1, 2006; 48(2): 211 - 212. [Full Text] [PDF] |
||||
![]() |
M. Herrera, P. A. Ortiz, and J. L. Garvin Regulation of thick ascending limb transport: role of nitric oxide Am J Physiol Renal Physiol, June 1, 2006; 290(6): F1279 - F1284. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. Stricklett, A. K. Hughes, and D. E. Kohan Endothelin-1 stimulates NO production and inhibits cAMP accumulation in rat inner medullary collecting duct through independent pathways Am J Physiol Renal Physiol, June 1, 2006; 290(6): F1315 - F1319. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Fryer, P. A. Rakestraw, P. N. Banfor, B. F. Cox, T. J. Opgenorth, and G. A. Reinhart Blood pressure regulation by ETA and ETB receptors in conscious, telemetry-instrumented mice and role of ETA in hypertension produced by selective ETB blockade Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2554 - H2559. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Dhaun, J. Goddard, and DavidJ. Webb The Endothelin System and Its Antagonism in Chronic Kidney Disease J. Am. Soc. Nephrol., April 1, 2006; 17(4): 943 - 955. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Silva, W. H. Beierwaltes, and J. L. Garvin Extracellular ATP Stimulates NO Production in Rat Thick Ascending Limb Hypertension, March 1, 2006; 47(3): 563 - 567. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Williams, X. Zhao, M. H. Wang, J. D. Imig, and D. M. Pollock Peroxisome Proliferator-Activated Receptor-{alpha} Activation Reduces Salt-Dependent Hypertension During Chronic Endothelin B Receptor Blockade Hypertension, August 1, 2005; 46(2): 366 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Herrera and J. L. Garvin Recent Advances in the Regulation of Nitric Oxide in the Kidney Hypertension, June 1, 2005; 45(6): 1062 - 1067. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Garvin and M. Herrera Physiological actions of renal collecting duct endothelin Am J Physiol Renal Physiol, May 1, 2005; 288(5): F910 - F911. [Full Text] [PDF] |
||||
![]() |
M. Herrera and J. L. Garvin A high-salt diet stimulates thick ascending limb eNOS expression by raising medullary osmolality and increasing release of endothelin-1 Am J Physiol Renal Physiol, January 1, 2005; 288(1): F58 - F64. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Bogzil, R. Eardley, and N. Ashton Relaxin-induced changes in renal sodium excretion in the anesthetized male rat Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2005; 288(1): R322 - R328. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Herrera and J. L. Garvin Endothelin stimulates endothelial nitric oxide synthase expression in the thick ascending limb Am J Physiol Renal Physiol, August 1, 2004; 287(2): F231 - F235. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Evans, R. E. Rose, J. M. Roeser, and J. D. Stidham NaCl transport across the opercular epithelium of Fundulus heteroclitus is inhibited by an endothelin to NO, superoxide, and prostanoid signaling axis Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2004; 286(3): R560 - R568. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Varela and J. L. Garvin Acute and Chronic Regulation of Thick Ascending Limb Endothelial Nitric Oxide Synthase by Statins J. Am. Soc. Nephrol., February 1, 2004; 15(2): 269 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Cowley Jr., T. Mori, D. Mattson, and A.-P. Zou Role of renal NO production in the regulation of medullary blood flow Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2003; 284(6): R1355 - R1369. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Taylor, C. E. Gariepy, D. M. Pollock, and J. S. Pollock Unique endothelin receptor binding in kidneys of ETB receptor deficient rats Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2003; 284(3): R674 - R681. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Taylor, C. E. Gariepy, D. M. Pollock, and J. S. Pollock Gender Differences in ET and NOS Systems in ETB Receptor-Deficient Rats: Effect of a High Salt Diet Hypertension, March 1, 2003; 41(3): 657 - 662. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Reinhart, L. C. Preusser, S. E. Burke, J. L. Wessale, C. D. Wegner, T. J. Opgenorth, and B. F. Cox Hypertension induced by blockade of ETB receptors in conscious nonhuman primates: role of ETA receptors Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1555 - H1561. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vanni, G. Polidori, I. Cecioni, S. Serni, M. Carini, and P. A. Modesti ETB Receptor in Renal Medulla Is Enhanced by Local Sodium During Low Salt Intake Hypertension, August 1, 2002; 40(2): 179 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Sasser, J. S. Pollock, and D. M. Pollock Renal endothelin in chronic angiotensin II hypertension Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2002; 283(1): R243 - R248. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Ortiz and J. L. Garvin Role of nitric oxide in the regulation of nephron transport Am J Physiol Renal Physiol, May 1, 2002; 282(5): F777 - F784. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Notenboom, D. S. Miller, P. Smits, F. G. M. Russel, and R. Masereeuw Role of NO in endothelin-regulated drug transport in the renal proximal tubule Am J Physiol Renal Physiol, March 1, 2002; 282(3): F458 - F464. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wang, O. A. Carretero, and J. L. Garvin Nitric Oxide Produced by THAL Nitric Oxide Synthase Inhibits TGF Hypertension, February 1, 2002; 39(2): 662 - 666. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. X. Li, M. Bek, L. D. Asico, Z. Yang, D. K. Grandy, D. S. Goldstein, M. Rubinstein, G. M. Eisner, and P. A. Jose Adrenergic and Endothelin B Receptor-Dependent Hypertension in Dopamine Receptor Type-2 Knockout Mice Hypertension, September 1, 2001; 38(3): 303 - 308. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Ortiz and J. L. Garvin Intrarenal Transport and Vasoactive Substances in Hypertension Hypertension, September 1, 2001; 38(3): 621 - 624. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. POLLOCK Contrasting pharmacological ETB receptor blockade with genetic ETB deficiency in renal responses to big ET-1 Physiol Genomics, June 6, 2001; 6(1): 39 - 43. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kramp, P. Fourmanoir, and N. Caron Endothelin resets renal blood flow autoregulatory efficiency during acute blockade of NO in the rat Am J Physiol Renal Physiol, December 1, 2001; 281(6): F1132 - F1140. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |